The first diagnostic procedures to detect prostate cancer have taken place in Dewsbury.

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...

Please provide your email address to receive an email when new articles are posted on . Women with functional hypothalamic amenorrhea receiving transdermal HT had greater increases in lumbar spine and ...

A new study released Tuesday found microplastics deep inside samples from 9 out of 10 patients with prostate cancer, with more microplastic levels inside tumors than in regular healthy tissue nearby.

Exact Imaging reported it has closed on $10 million in financing in a round led by iGan Partners. The Toronto-based company said proceeds will be used to help with sales and adoption of the ExactVu ...